BioMarin, Glyko Biomedical Ltd. deal

BMRN will acquire GBL, which owns 11.4 million shares (22%) of BMRN. Under the deal, BMRN will acquire all of GBL’s shares, retire the 11.4 million BMRN shares owned by GBL and issue 11.4 million new ...